Comparison of immunogenicity between a candidate live attenuated vaccine and an inactivated vaccine for Cache Valley virus

Ayers, V. B., Huang, Y.-J. S., Kohl, A. , Dunlop, J. I., Hettenbach, S. M., Park, S. L., Higgs, S. and Vanlandingham, D. L. (2023) Comparison of immunogenicity between a candidate live attenuated vaccine and an inactivated vaccine for Cache Valley virus. Viral Immunology, 36(1), pp. 41-47. (doi: 10.1089/vim.2022.0103) (PMID:36622942) (PMCID:PMC9885547)

[img] Text
289329.pdf - Published Version
Available under License Creative Commons Attribution.

256kB

Abstract

Cache Valley virus (CVV) is a mosquito-borne bunyavirus that is enzootic throughout the new world. Although CVV is known as an important agricultural pathogen, primarily associated with embryonic lethality and abortions in ruminants, it has recently been recognized for its expansion as a zoonotic pathogen. With the increased emergence of bunyaviruses with human and veterinary importance, there have been significant efforts dedicated to the development of bunyavirus vaccines. In this study, the immunogenicity of a candidate live-attenuated vaccine (LAV) for CVV, which contains the deletion of the nonstructural small (NSs) and nonstructural medium (NSm) genes (2delCVV), was evaluated and compared with an autogenous candidate vaccine created through the inactivation of CVV using binary ethylenimine (BEI) with an aluminum hydroxide adjuvant (BEI-CVV) in sheep. Both 2delCVV and BEI-CVV produced a neutralizing antibody response that exceeds the correlate of protection, that is, plaque reduction neutralization test titer >10. However, on day 63 postinitial immunization, 2delCVV was more immunogenic than BEI-CVV. These results warrant further development of 2delCVV as a candidate LAV and demonstrate that the double deletion of the NSs and NSm genes can be applied to the development of vaccines and as a common attenuation strategy for orthobunyaviruses.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Dunlop, Dr James and Kohl, Professor Alain
Authors: Ayers, V. B., Huang, Y.-J. S., Kohl, A., Dunlop, J. I., Hettenbach, S. M., Park, S. L., Higgs, S., and Vanlandingham, D. L.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity > Centre for Virus Research
Journal Name:Viral Immunology
Publisher:Mary Ann Liebert
ISSN:0882-8245
ISSN (Online):1557-8976
Published Online:09 January 2023
Copyright Holders:Copyright © 2023 Victoria B. Ayers et al.
First Published:First published in Viral Immunology 36(1): 41-47
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
171267US-UK BBSRC-NIFA Collab: Control of emerging bunyavirusesAlain KohlBiotechnology and Biological Sciences Research Council (BBSRC)BB/M027112/1III-MRC-GU Centre for Virus Research
172630007Arthropod-borne infections and emerging virus infections in high risk areas (Programme 4)Alain KohlMedical Research Council (MRC)MC_UU_12014/8III - Centre for Virus Research